GSK "MONOLIT", Moscow

Accounting reports

Previously








Share:
Name
GARAZHNO-STOYANOCHNYY KOOPERATIV "MONOLIT"
INN
7728793245
KPP
772801001
OGRN
5117746012995
OKPO
37328573
Address
117312, G.moskva, pr-kt 60-letiya Oktyabrya, d. D.19

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract
We guarantee to provide you with an actual
information extract

Data on types of economic activities
GSK "MONOLIT" according to EGRUL

OKVED codeTypeName of activity type
82.99Core activityOther business support services to businesses and individuals not otherwise specified
74.20Additional activityInterior Design and Interior Design
74.30Additional activityTranslation and interpretation activities
All types of activities
82.92Additional activity Activities of packing goods
Registration date
13.12.2011
Registering department
Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby 46 po g. Moskve

GSK "MONOLIT" (Moscow; INN 7728793245) was registered on 13 Dec 2011. Type of ownership of GSK "MONOLIT" - Comsumer cooperatives.

Form of ownership of GSK "MONOLIT" - Private property.

Principal activities of GSK "MONOLIT": other business support services to businesses and individuals not otherwise specified (82.99), interior design and interior design (74.20), translation and interpretation activities (74.30).

Economic indicators

2023

Net loss (RAS) of GSK MONOLIT increased by 9.51% to 4.93 million RUB from 4.50 million RUB over 2022, the company informed.

Revenue decreased in the accounting period by 6.33% to 1.07 million RUB from 1.14 million RUB in 2022.

2022

Net loss (RAS) of GSK MONOLIT increased by 4.89% to 4.72 million RUB from 4.50 million RUB over 2021, the company informed.

Revenue decreased in the accounting period 2.21 times to 514.00 thousand RUB from 1.14 million RUB in 2021.

2021

Net loss (RAS) of GSK MONOLIT increased 2.61 times to 4.50 million RUB from 1.72 million RUB over 2020, the company informed.

Revenue decreased in the accounting period by 44.99% to 1.14 million RUB from 2.07 million RUB in 2020.

2019

Net loss (RAS) of GSK MONOLIT increased by 34.11% to 2.76 million RUB from 2.06 million RUB over 2018, the company informed.

Revenue decreased in the accounting period by 3.75% to 1.95 million RUB from 2.03 million RUB in 2018.

2018

Net loss (RAS) of GSK MONOLIT dropped over 2018 by 17.22% to 2.06 million RUB from 2.49 million RUB KAgent.Entities.Balance, the company informed.

Revenue decreased in the accounting period by 2.41% to 2.03 million RUB from 2.08 million RUB in 2017; cost of goods sold decreased by 10.70% to 3.97 million RUB from 4.45 million RUB; sales loss decreased by 17.96% to 1.95 million RUB from 2.37 million RUB.

2017

Net loss (RAS) of GSK MONOLIT increased 10.11 times to 2.50 million RUB from 247.00 thousand RUB over 2016, the company informed.

Revenue increased in the accounting period by 25.64% to 2.10 million RUB from 1.67 million RUB over 2016; cost of goods sold grew 2.32 times to 4.41 million RUB from 1.90 million RUB; sales loss grew 10.10 times to 2.30 million RUB from 228.00 thousand RUB.

2016

Net loss (RA) of GSK MONOLIT made up 185.00 thousand RUB over 2016 compared to net profit of 112.00 thousand RUB over 2015, the company informed.

Revenue increased in the accounting period by 35.03% to 1.67 million RUB from 1.24 million RUB over 2015; cost of goods sold grew 1.65 times to 1.84 million RUB from 1.12 million RUB; sales loss made up 166.00 thousand RUB compared to sales profit of 122.00 thousand RUB.

2014

Net profit (RAS) of GSK MONOLIT dropped in 2014 by 35.75% to 248.00 thousand RUB from 386.00 thousand RUB over the same period in 2013, the company informed.

Revenue remained in the accounting period at the same level and made up 1.73 million RUB compared to 1.73 million RUB 1.73 million RUB; cost of goods sold grew by 9.74% to 1.34 million RUB from 1.22 million RUB; sales profit fell by 23.83% to 390.00 thousand RUB from 512.00 thousand RUB.

2013

Net profit (RAS) of GSK MONOLIT dropped in 2013 2.74 times to 76.00 thousand RUB from 208.00 thousand RUB over the same period in 2012, the company informed.

Revenue increased in the accounting period 18.45 times to 1.73 million RUB from 94.00 thousand RUB over 2012; cost of goods sold grew 12.87 times to 1.53 million RUB from 119.00 thousand RUB; sales profit made up 202.00 thousand RUB compared to sales loss of 25.00 thousand RUB.




Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Companies in the region

Guarantees

Guarantees
We guarantee
provision of
relevant
information

Payment methods


Statistics
Companies
12 288 329
Reports
17 430 699
Rrocessed requests
Extract from EGRUL:
Today, 6:58 AM
Accounting reports:
Today, 6:58 AM
The site can contain materials of 16+ category
+7(495) 729−17−96,    info@k-agent.ru
Рейтинг@Mail.ru © "Info-RL", 2006—2024
About the project    Legal basis
Business Business Services Others Info-RL, ООО
Moscow ul. Kazakova, d. 3, str. 4 105064
+7(495) 729−17−96 7 days a week info@k-agent.ru